The Primary Progressive Multiple Sclerosis market is undergoing a period of significant evolution, largely influenced by new therapeutic developments, shifting epidemiological trends, and a deeper understanding of patient-reported outcomes (PROs). As a chronic and disabling subtype of multiple sclerosis, Primary Progressive Multiple Sclerosis (PPMS) is characterized by gradual neurological...